What about TLT's earlier mouse studies? (see the landing page for TLTFF here on Inv Hub). Company states that in animal studies, there was NO RECURRENCE after 20 months. Company claims those animal cancer(s) were CURED. Of course, humans are not mice, but... given the mechanisms at work here....something tells me today's admittedly horrible selloff was VERY OVERDONE...a highly emotional, disappointed response to "in progress" news that seems less than 100% definitively positive. But was the news in fact disappointing, given that patients 1-3 were were given half the therapeutic dose ?? Why would anyone expect a total cure with half dosing? Would have been wonderful but...was that ever a realistic expectation?? I don't have the knowledge to answer that but...perhaps others here do...
I too am not quite sure why the company chose to release this news today, but now that they have i am hoping they will have more to say about certain parts of it such as recurrence possibly being caused by unrelated "upstream" UUTUC. I don't know if it is "against the rules" --- or the etiquette of clinicals -- but i think if it isn't, the company could benefit by further explaining -- and in lay terms -- today's announced results and why they may have been mistakenly -- and away prematurely -- interpreted by the marketplace as some kind of failure.
A thoughtful and considered letter to shareholders by Roger could go a long way toward setting things straight more clearly..and getting investor psychology, so seemingly damaged today, back on a more positive track...
fwiw...
thoughts?
